Login/Sign Up
₹17794*
MRP ₹21700
18% off
₹18445*
MRP ₹21700
15% CB
₹3255 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Available Offers
Whats That
About Monovisc Injection 4 ml
Monovisc Injection 4 ml belongs to the class of medicines called non-steroidal anti-inflammatory drugs (NSAIDs) used in the treatment of knee pain due to osteoarthritis in patients who have failed to respond adequately to simple painkillers or physical therapy and exercise. Osteoarthritis is a degenerative joint disease in which the two ends of the joints come together due to the breakdown of a protective covering of cartilage. Due to the absence of this protective covering, the joints rub against each other, leading to pain and stiffness.
Monovisc Injection 4 ml contains Sodium hyaluronate, which works by restoring synovial fluid in the knee that helps to lubricate and cushion the joint during movement. Thereby it reduces pain.
Monovisc Injection 4 ml will be administered by a healthcare professional; do not self-administer. In some cases, you may experience certain common side effects such as pain, swelling, redness, and warmth at the injection site or fluid in the joint. Most of these side effects do not require medical attention and will resolve gradually over time. However, if the side effects persist or worsen, please consult your doctor.
If you are allergic to Sodium hyaluronate or products from birds such as eggs, feathers and poultry, inform your doctor before receiving Monovisc Injection 4 ml. If you are a pregnant or breastfeeding woman, inform your doctor before receiving Monovisc Injection 4 ml. Monovisc Injection 4 ml is not recommended for children as safety and effectiveness have not been established. Monovisc Injection 4 ml should be used with caution in patients with pre-existing chondrocalcinosis (accumulation of calcium salts in hyaline cartilage or fibrocartilage) as it may lead to an acute attack of the condition.
Uses of Monovisc Injection 4 ml
Directions for Use
Medicinal Benefits
Monovisc Injection 4 ml contains Sodium hyaluronate, a non-steroidal anti-inflammatory drug (NSAID) used in the treatment of knee pain due to osteoarthritis in patients who have failed to respond adequately to simple painkillers or physical therapy and exercise. It works by restoring synovial fluid in the knee that helps to lubricate and cushion the joint during movement. Thereby it reduces pain by decreasing friction in the joints.
How Monovisc Injection 4 ml Works
Storage
Side Effects of Monovisc Injection 4 ml
What if I have taken an overdose of Monovisc Injection 4 ml
Drug Warnings
If you are allergic to Sodium hyaluronate or products from birds such as eggs, feathers and poultry, inform your doctor before receiving Monovisc Injection 4 ml. If you are a pregnant or breastfeeding woman, inform your doctor before receiving Monovisc Injection 4 ml. Monovisc Injection 4 ml is not recommended for children as safety and effectiveness have not been established. Monovisc Injection 4 ml should be used with caution in patients with pre-existing chondrocalcinosis (accumulation of calcium salts in hyaline cartilage or fibrocartilage) as it may lead to an acute attack of the condition. Avoid activities such as tennis, heavy lifting, jogging, or standing on your feet for a long time immediately after receiving Monovisc Injection 4 ml and for the next 48 hours.
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
Alcohol
Consult your doctor
The interaction of Monovisc Injection 4 ml with alcohol is unknown. If you have any concerns regarding this, please discuss them with your doctor.
Pregnancy
Consult your doctor
The safety and effectiveness of Monovisc Injection 4 ml in pregnant women have not been established. Therefore, if you are pregnant or planning for pregnancy, please inform your doctor before receiving Monovisc Injection 4 ml.
Breast Feeding
Consult your doctor
The safety and effectiveness of Monovisc Injection 4 ml in breastfeeding women have not been established. Therefore, please inform your doctor if you are breastfeeding before receiving Monovisc Injection 4 ml.
Driving
Caution
Drive only if you are alert after receiving Monovisc Injection 4 ml.
Liver
Consult your doctor
If you have a pre-existing or a history of liver disease, please inform your doctor before receiving Monovisc Injection 4 ml.
Kidney
Consult your doctor
If you have a pre-existing or a history of kidney disease, please inform your doctor before receiving Monovisc Injection 4 ml.
Children
Unsafe
Monovisc Injection 4 ml is not recommended for children and adolescents (age 21 years or younger) as the safety and effectiveness of Monovisc Injection 4 ml have not been established in that age group.
Monovisc Injection 4 ml is used in the treatment of knee pain due to osteoarthritis in patients who have failed to respond adequately to simple painkillers or physical therapy and exercise.
Monovisc Injection 4 ml contains Sodium hyaluronate, a non-steroidal anti-inflammatory drug (NSAID) which works by restoring synovial fluid in the knee that helps to lubricate and cushion the joint during movement. Thereby it reduces knee pain due to osteoarthritis.
You are recommended to avoid activities such as tennis, heavy lifting, jogging, or standing on your feet for a long time immediately after receiving Monovisc Injection 4 ml and for the next 48 hours. Discuss with your doctor regarding the appropriate time to resume these activities.
Monovisc Injection 4 ml should not be used in patients with infections, knee joint infections, or skin disease in the area at the injection site. Also, Monovisc Injection 4 ml should not be administered to patients with known allergies to Sodium hyaluronate.
Country of origin
Manufacturer/Marketer address
Keep Refrigerated. Do not freeze.
We provide you with authentic, trustworthy and relevant information